US2001021501A1PendingUtilityA1

Mixed cell diagnostic systems

Assignee: DIAGNOSTIC HYBRIDS INCPriority: Apr 24, 1998Filed: Mar 23, 2001Published: Sep 13, 2001
Est. expiryApr 24, 2018(expired)· nominal 20-yr term from priority
C12N 5/0697C12N 2503/04G01N 2333/295G01N 33/50G01N 33/569C12Q 1/10G01N 33/53C12N 2502/256C12Q 1/04G01N 2333/29G01N 33/5044G01N 33/5091C12N 2502/27
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention generally relates to the field of diagnostic microbiology, and, more particularly, to compositions and methods for detecting and differentiating one or more viruses or other intracellular parasites present in a specimen. The present invention also provides compositions and methods to evaluate the susceptibility of a organisms to antimicrobial agents.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for the detection of enterovirus in a sample, comprising: 
 a) providing: 
 i) a sample suspected of containing enterovirus; and  
 ii) a mixed cell culture comprising at least two cell types, wherein said cell types comprise RD cells and human mucoepidermoid cells;  
   b) inoculating said mixed cell culture with at least a portion of said sample to produce an inoculated culture; and    c) observing said inoculated culture for the presence of said enterovirus.    
     
     
         2 . The method of    claim 1   , wherein said human mucoepidermoid cell is H292.  
     
     
         3 . The method of    claim 1   , wherein said enterovirus is selected from Coxsackie viruses, echoviruses, and polioviruses.  
     
     
         4 . A method for the detection of enterovirus in a sample, comprising: 
 a) providing: 
 i) a sample suspected of containing enterovirus; and  
 ii) a mixed cell culture comprising at least two cell types, wherein one of said cell types comprises Caco-2 cells;  
   b) inoculating said mixed cell culture with at least a portion of said sample to produce an inoculated culture; and    c) observing said inoculated culture for the presence of said enterovirus.    
     
     
         5 . The method of    claim 4   , wherein said cell type other than said Caco-2 cells is selected from RD cells, H292 cells, BGMK cells, and A549 cells.  
     
     
         6 . The method of    claim 4   , wherein said enterovirus is selected from Coxsackie viruses, echoviruses, polioviruses, rotaviruses, astroviruses, and adenoviruses.  
     
     
         7 . A method for the detection and identification of parainfluenza virus in a sample, comprising the steps of: 
 a) providing: 
 i) a sample suspected of containing parainfluenza virus; and  
 ii) a mixed cell culture comprising at least two cell types, wherein one of said cell types comprises mink lung cells;  
   b) inoculating said mixed cell culture with at least a portion of said sample to produce an inoculated culture; and    c) observing said inoculated culture for the presence of said parainfluenza virus.    
     
     
         8 . The method of    claim 7   , wherein said mink lung cells are Mv1Lu cells.  
     
     
         9 . The method of    claim 7   , wherein said parainfluenza virus is selected from type 1, type 2 and type 3.

Join the waitlist — get patent alerts

Track US2001021501A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.